UniProt ID ▼ | Protein Name | Gene Symbol | No. of Glycosylation Sites | No. of GlyTouCan IDs | Disease Ontology |
---|---|---|---|---|---|
G1QHZ5 | Pannexin 2 |
|
1 | 0 |
|
A0A2I3HYW4 | Angiotensin-converting enzyme |
|
12 | 0 |
|
A0A2I3HYQ1 | Angiotensin-converting enzyme |
|
6 | 0 |
|
A0A2I3HUP6 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A2I3HUC2 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I3HP72 | N-acetylgalactosamine-6-sulfatase |
|
2 | 0 |
|
A0A2I3HLU3 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I3HKE6 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A2I3HK83 | P2X purinoceptor |
|
1 | 0 |
|
A0A2I3HK80 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I3HK45 | Voltage-dependent P/Q-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I3HJT5 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I3HJ79 | Peptidylglycine alpha-amidating monooxygenase |
|
1 | 0 |
|
A0A2I3HH16 | GDNF family receptor alpha-1 |
|
2 | 0 |
|
A0A2I3HGL4 | Noggin |
|
1 | 0 |
|
A0A2I3HFA4 | L-selectin |
|
3 | 0 |
|
A0A2I3HEC6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A2I3HCK1 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A2I3H8C4 | Proto-oncogene tyrosine-protein kinase receptor Ret |
|
1 | 0 |
|
A0A2I3H2F6 | Hyaluronidase |
|
1 | 0 |
|
A0A2I3H1K0 | L-selectin |
|
3 | 0 |
|
A0A2I3GXY6 | Fibroblast growth factor receptor |
|
8 | 0 |
|
A0A2I3GUX9 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
A0A2I3GUL6 | Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase |
|
1 | 0 |
|
A0A2I3GR19 | Voltage-dependent L-type calcium channel subunit alpha |
|
1 | 0 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024